SEC FORM 4
$2,946,149.56
Alto Neuroscience, Inc. (ANRO)
Sale of 110,830 shares at $26.5826 per share.
Reporting Person Smith Nicholas Conrad · Officer Title PRESIDENT AND CFO · Transaction Code S
Traded Sep 29, 2026 · Disclosed Oct 1, 2026
Source: SEC Form 4 · 0002009130-26-000004 · filed 2026-10-01 · View filing →